Few of the most popular early treatments for autism are supported by strong evidence, according to two new studies.

A new resource that details the ages at which children attain milestones such as speaking and walking could help clinicians spot autism sooner.

This year’s top papers deepen our understanding of autism’s genetics and reveal mixed results from trials of autism therapies.

Understanding how gaze differs in autistic people may help improve their lives.

Turning down the expression of a gene linked to autism leaves zebra finches singing disorganized songs.

People with autism process the pitch and emotional tone in speech differently than their neurotypical peers — which may make it harder for them to pick up on nuances of social communication.

Studies of Rett syndrome hint at genes, cells and brain circuits that may be involved in autism — and may pave the way to treatments for both conditions.

A new study supports the view that songbirds offer a good model to study speech learning in autistic children.

Autistic children who lose words reach key milestones earlier than autistic children without language regression.

Researcher Randi Hagerman is a big proponent of metformin — a diabetes drug that she is testing in people with fragile X syndrome. In fact, Hagerman takes the drug herself as a preventive measure against cancer.